Neurotransmitters + UDH III

Description

Neurotransmitters + UDH III

A specialized urine test panel that measures metabolites of key neurotransmitters including serotonin, dopamine, norepinephrine, epinephrine, GABA, glutamate, and histamine, along with advanced urinary dopamine metabolites such as 3-methoxytyramine (3-MT), 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA). This comprehensive analysis provides detailed insights into dopamine synthesis, metabolism, and breakdown pathways, supporting evaluation of nervous system health, mood regulation, cognitive function, and neurodegenerative risk. It is particularly useful for diagnosing and managing conditions like Parkinson’s disease, mood disorders, ADHD, chronic fatigue, and other neurological or psychiatric disorders. The test enables personalized therapeutic approaches through nutrition, supplements, and lifestyle modifications aimed at optimizing neurotransmitter balance and dopamine metabolism.

Categories by Disease

• Neurodegenerative diseases (Parkinson’s, Lewy body dementia)
• Mood and anxiety disorders
• Neurodevelopmental conditions (ADHD, autism spectrum)
• Chronic fatigue syndrome and fibromyalgia
• Stress-related hormonal and neurotransmitter imbalances

Categories by Symptoms

• Motor dysfunctions such as tremors, rigidity
• Anxiety, depression, mood swings
• Cognitive impairment, poor concentration
• Fatigue and low motivation
• Sleep disturbances and restlessness

Categories by Lifestyle

• Exposure to neurotoxins or heavy metals
• Chronic psychological or physical stress
• Poor nutrition affecting neurotransmitter synthesis
• Use of medications altering dopamine pathways
• Sleep deprivation and circadian rhythm disruptions

Categories by Diagnostic Methods

• Urine analysis using high-performance liquid chromatography (HPLC) or mass
  spectrometry quantifying neurotransmitter metabolites including 3-MT, DOPAC,
  and HVA
• Provides detailed functional assessment of dopamine metabolism and overall
  neurotransmitter status